Latest filing published 15 Jul 2026 for PharmaCorp Rx Inc..
Insider track record
James Dumont: trading record in brief
James Dumont is a declared insider of PharmaCorp Rx Inc., with filings sourced from SEDI. We count 9 filings; the first trade dates from 6 June 2024 and the latest from 9 July 2026.
The filings describe grants, exercises and other transfers rather than trades on the open market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
Most recently, on 15 July 2026, the filings show a transaction worth €6,420 in PharmaCorp Rx Inc. The median gap between a trade and its publication by SEDI is 6 days. This delay matters because a trade only becomes useful information once it is public. These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.
Companies and markets linked to James Dumont
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- WarrantsTSXSEDI:4752540
- 17,353 shares@ CA$0.6037.0% of flowWarrantsTSXSEDI:4752538
- WarrantsTSXSEDI:4752537
- 34,706 shares@ CA$0.510.021% mcap63.0% of flowCommon SharesTSXSEDI:4752520
- 178,650 shares@ CA$0.4258.5% of flowCommon SharesTSXSEDI:4605982
- 59,524 shares@ CA$0.4219.5% of flowCommon SharesTSXSEDI:4605991
- Common SharesTSXSEDI:4605990
7 of 7 declarations
